Tesamorelin: what it is and what the research shows
The GHRH analogue mechanism, the narrow approved visceral-fat indication, how tesamorelin differs from recovery peptides, and where general fat-loss and longevity claims go too far.
Plain-English answers to the questions researchers and the curious public actually ask about peptides - no hype, every claim traced to a primary source.
17 articles tagged “Explainers”
The GHRH analogue mechanism, the narrow approved visceral-fat indication, how tesamorelin differs from recovery peptides, and where general fat-loss and longevity claims go too far.
PT-141 is an FDA-approved melanocortin-4 receptor agonist for hypoactive sexual desire disorder. How it works, clinical evidence from the DESIRE trials, nasal spray vs injection, comparison to Viagra/Cialis, dosage, side effects, and why the mechanism differs from phosphodiesterase inhibitors.
A 503A compounding-list review is not a change of FDA position. What the July 23-24, 2026 Pharmacy Compounding Advisory Committee meeting really means for BPC-157, TB-500, Semax, Epitalon and peptide regulation.
As peptides become a bigger public-health story around the FDA's July 2026 review, audiences need clearer information about BPC-157, TB-500, Semax, Epitalon and the 503A Bulks List. A plain-English guide to reading the coverage - FDA review is not FDA approval.
How peptides went from FDA Category 2 prohibition in 2023 to a fresh 503A review in 2026 - the April 2026 Federal Register notice, the 12 peptides under review, the compounder lawsuits, the HHS policy push, and what the July 2026 PCAC meeting will decide.
A 2026 review in Frontiers in Aging maps nine therapeutic peptides onto the hallmarks of aging - from tirzepatide and Epitalon to GHK-Cu, BPC-157, TB-500, Semax, CJC-1295/Ipamorelin and PT-141 - separating FDA-approved agents from investigational compounds.
FDA-approved injectable medicines vs unapproved research compounds, what the 2026 press wave (Guardian, AP, MIT Tech Review, AMA) actually reported, and whether peptide injections are safe. Research use only; not for human use; not medical advice.
What bacteriostatic water is, bacteriostatic vs sterile water, exactly how much to add (the concentration = mass ÷ volume math), shelf life and storage, and the reconstitution technique. The standard solvent for research-peptide reconstitution. Research use only.
Amino acids are the monomers; peptides are short chains of them joined by peptide bonds. The plain-English hierarchy - amino acid → peptide → protein - and why sequence is a compound’s identity when reading peptide research.
Yes - semaglutide is a 31-amino-acid peptide and a GLP-1 receptor agonist. What GLP-1 actually is, how the class works, and why an approved medicine is a different category from a research reagent.
The honest answer depends on the compound and how it is sold. A plain-English map of the EMA, FDA and MHRA framing - and what “research use only” actually means.
“What is better, TRT or peptides?” is partly a category error. A neutral explainer on how clinics and the literature frame testosterone replacement, enclomiphene and peptide signalling - mechanisms, not a verdict.
Signal peptides, copper peptides (GHK-Cu) and collagen peptides are three different things marketed as one. What the dermatology literature actually supports - in plain English.
No - amino-acid chains versus a cholesterol-derived ring system, with different receptors and signalling routes. Why the categories get confused, and the one-sentence way to tell them apart.
A neutral explainer on the gap between the narrow regulated meaning and the loose marketing one - approved medicines vs investigational compounds, and why the language is scrutinised.
Which peptides actually have a hair-relevant research literature (GHK-Cu leads), and the crucial difference between “studied mechanism” and “proven outcome.”
Short chains of amino acids that signal the body to repair, regenerate and regulate. Why billionaires and A-list actors have been running them privately since 2010 - and why the rest of the world is finally catching up.
Research use only. These articles summarise public literature and catalogue facts. They do not diagnose, treat, or prevent any disease, and are not medical advice.